Opticrom Allergy Single Dose (Sodium Cromoglicate)

Sodium cromoglicate is used to manage allergic conditions by stabilizing mast cells and preventing mediator release.

• Seasonal allergic rhinitis: reduces nasal congestion, sneezing and itching.
• Allergic conjunctivitis: alleviates eye itching, redness and tearing.
• Mast cell‑mediated asthma prophylaxis: helps prevent bronchospasm when taken before known allergen exposure.

• Sodium cromoglicate binds to calcium channels on mast cells, inhibiting calcium influx that is required for degranulation. By preventing the release of histamine, leukotrienes and other inflammatory mediators, it stabilizes mast cells and reduces the cascade of allergic inflammation without significant systemic absorption.

Adverse reactions may occur with any medication, and patients should be aware of both common and rare events.

Common Side Effects

• Taste disturbance: mild alteration of taste perception.
• Nausea: occasional feeling of stomach upset.
• Headache: transient mild headache.
• Abdominal discomfort: mild cramps or discomfort.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Severe abdominal pain: persistent or worsening pain.
• Blood dyscrasias: rare changes in blood cell counts.
• Angioedema: swelling of face, lips or tongue.
• Respiratory distress: unexpected difficulty breathing.

Before using Opticrom Allergy Single Dose, consider the following safety measures.

• Pregnancy: consult a healthcare professional; limited data are available.
• Breastfeeding: discuss risks and benefits with a physician.
• Renal impairment: use with caution; monitor renal function.
• Pediatric use: dosage and safety should be determined by a pediatric specialist.
• Concomitant mast cell stabilizers: assess need for combined therapy.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Sodium cromoglicate may interact with other medications; awareness of the interaction level helps guide monitoring.

Major Interactions (Avoid)

• Concurrent use of other mast cell stabilizers: may increase local irritation.
• High‑dose corticosteroids: can mask the need for cromoglicate therapy.

Moderate Interactions (Monitor Closely)

• Antihistamines: additive effect on symptom control; monitor for excessive sedation.
• Bronchodilators: assess response to ensure adequate asthma control.
• Oral contraceptives: no known interaction, but monitor for any unexpected side effects.
• Anticholinergic agents: may increase dry‑mouth sensation.